WO2024261647 - IMPROVED SEED VIRUSES

National phase entry:
Publication Number WO/2024/261647
Publication Date 26.12.2024
International Application No. PCT/IB2024/055963
International Filing Date 19.06.2024
Title **
[English] IMPROVED SEED VIRUSES
[French] VIRUS DE SEMENCE AMÉLIORÉS
Applicants **
SEQIRUS INC.
Inventors
EKBERG, Gregory
MCGEE, Charles
ERNST, Terika
GULLY, Christopher
Priority Data
63/508,946   19.06.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3651
EPO Filing, Examination, Granting28068
Japan Filing, Examination, Granting2958
South Korea Filing, Examination, Granting3866
USA Filing, Examination, Granting15560
MasterCard Visa
Total: 54,103

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present disclosure relates to the field of influenza viruses. More particularly, this disclosure relates to donor or seed influenza viruses for use in preparing reassortant influenza viruses for vaccine production.[French] La présente divulgation se rapporte au domaine des virus de la grippe. La présente divulgation concerne plus particulièrement les virus grippaux donneurs ou de semence destinés à être utilisés dans la préparation de virus grippaux réassortis pour la production de vaccins.